Growth during and after a trial of growth hormone releasing hormone 1-29 in children with idiopathic short stature or growth hormone neurosecretory dysfunction

Journal of Pediatric Endocrinology and Metabolism

Volumn 13, Issue 6, 2000, Pages 645-650

  Schwartz, I David ^a,b   Grunt, Jerome A ^a   Berg, Sandy ^a   Jacobson, Jill D ^a   Moore, Wayne V ^a   Howard, Campbell P ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN S MERCY HOSPITAL   (United States)

Author keywords

Growth hormone; Growth hormone releasing hormone (GHRH, GRF); Short stature

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR RECEPTOR;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; FOLLOW UP; GROWTH HORMONE DEFICIENCY; GROWTH RATE; HORMONE DETERMINATION; HUMAN; IDIOPATHIC DISEASE; MALE; PREPUBERTY; SCHOOL CHILD; SHORT STATURE; TREATMENT OUTCOME;

EID: 0033934504     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2000.13.6.645     Document Type: Article

References (12)

1. Romer TE, Rymkiewicz-Kluczynska B, Olwer M, Sagnard L, Szarras-Czapnik M. Growth hormone-releasing hormone reverses secondary somatotroph unresponsiveness. J Clin Endocrinol Metab 1990; 72: 503-506.
2. Lievre M, Chatelain P, Van Vliet G, Oliver M, Blanchard J, Morre M, Boissel JP. Treatment with growth hormone-releasing hormone (GHRH) 1-44 in children with idiopathic growth hormone deficiency: a randomized, double-blind dose-effect study. Fundam Clin Pharmacol 1992; 6: 359-366.
3. Duck SC, Schwarz HP, Costin G, Rapaport R, Arslanian S, Hayek A, Connors M, Jaramillo J. Subcutaneous growth hormone-releasing hormone therapy in growth hormone deficient children: First year of therapy. J Clin Endocrinol Metab 1992; 75: 1115-1120.
4. 2 compared with growth hormone. Acta Paediatr 1993; Suppl 388: 16-21.
5. Thorner M, Rochiccioli P, Colle M, Lanes R, Grunt J, Galazka A, Landy H, Eengrand P, Shah S. Once daily subcutaneous growth hormone-releasing therapy accelerates growth in growth hormone-deficient children during the first year of therapy. J Clin Endocrinol Metab 1996; 81: 1189-1195.
6. Lanes, R, Carrillo E, Venezuelan Collaborative Study Group. Long term therapy with a single daily subcutaneous dose of growth hormone releasing hormone (1-29) in pre-pubertal growth hormone deficient children. J Pediatr Endocrinol 1994; 7: 303-308.
7. 2 in children with idiopathic short stature induces a sustained increase in growth velocity. Clin Endocrinol 1994; 41: 487-493.
8. Grunt JA, Schwartz ID, Buchanan C, Howard CP. Effects of long term growth hormone releasing hormone 1-29 in significantly short children. Acta Paediatr 1995; 84: 631-633.
9. 2. J Clin Endocrinol Metab 1992; 75: 1255-1269.
10. Spiliotis BE, August GP, Hung W, Sonis W, Mendelson W, Bercu BB. Growth hormone neurosecretory dysfunction: a treatable cause of short stature. JAMA 1984; 251: 2223-2230.
11. nd Ed. Stanford, CA: Stanford University Press, 1959.
12. Duck SC, Rapaport R. Long-term treatment with GHRH [1-44] amide in prepubertal children with classical growth hormone deficiency. J Pediatr Endocrinol Metab 1999; 12:531-536.